Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-784-1 | CAS number: 68608-50-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
It is considered from the results that all the substances in the category of lithium salts of C14-C22 monocarboxylic acids exhibit a similar lack of acute oral and dermal toxicity potential across the entire category. There is no evidence of a relevant intrinsic acute oral or dermal toxicity requiring classification or substance specific RMMs. An estimate of the inhalative dust/mist toxicity by route-to-route extrapolation result in an ATE well above the cut-off values for classification for acute inhalation toxicity hazard.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High. Reliable, adequate and relevant data available to fulfill the tonnage-driven data requirements of REACH. Tested substance is representative of the lithium salts of C14-C22 fatty acids category and can be read across to other category members.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- High. Reliable, adequate and relevant data available to fulfill the tonnage-driven data requirements of REACH. Tested substance is representative of the lithium salts of C14-C22 fatty acids category and can be read across to other category members.
Additional information
The substances in the category are considered to be similar on the basis that they have common structures of a lithium ion varying only by the length of the fatty acid chain and the presence of unsaturated and/or hydroxyl functional groups. As a result, it is expected that the substances will have similar, predictable properties. Due to the close structural similarity and the narrow range of carbon chain numbers covered in this category, the acute toxicity potential is expected to be similar across the category.
Although fatty acids C18 (unsaturated) lithium salts is not in the list of substances being registered, this substance falls within the definition of the lithium salts of fatty acids C14-C22 category (see Category Justification Document) by virtue of its chemical structure and therefore read across from data on fatty acids C18 (unsaturated) lithium salts to other members of the category is considered to be justified.
A number of key acute oral and dermal toxicity studies in rats have been conducted on lithium salts of myristic (C14), 12-hydroxystearic (C18 hydroxylated), stearic (C18), C18 unsaturated, and behenic (C22) monocarboxylic acids. The results from these studies showed no evidence of acute toxicity up to the highest doses tested (2000 mg/kg or greater). In addition, several supporting acute toxicity studies on lithium 12 -hydroxystearate in rats and rabbits have also been considered which, on a weight of evidence basis, provide data which supports the lack of acute toxicity of the lithium salts of C14 -C22 monocarboxylic acids. Several of the latter studies were conducted on the substance contained within a grease base at lower concentrations. However, no conflicting results were seen, and the data also supports the low acute toxicity of the category members.
It is considered from the results that all the substances in the category of lithium salts of C14-C22 monocarboxylic acids exhibit a similar, lack of acute oral and dermal toxicity potential across the entire category. There is no evidence of a relevant intrinsic acute oral or dermal toxicity requiring classification or substance specific RMMs. An estimate of the inhalation dust/mist toxicity by route-to-route extrapolation using conservative standard default values results in an ATE of 10.4 mg/L/4h minimum. This value is well above the cut values for classification for acute inhalation toxicity hazard.
Justification for selection of acute toxicity – oral endpoint
The data are representative of the lithium salts of C14 - C22 fatty
acid substances and can be read across to other category members.
Justification for selection of acute toxicity – dermal endpoint
The data are representative of the lithium salts of C14 - C22 fatty
acid substances and can be read across to other category members.
Justification for classification or non-classification
The oral and dermal LD50 values are greater than 2000 mg/kg bw. An estimate of the inhalation dust/mist toxicity by route-to-route extrapolation according to ECHA CLP TGD 3.1.3.3.4i results in an ATE well above the cut-off values for classification for acute inhalation toxicity hazard.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.